Identification of a third autonomous activation domain within the human estrogen receptor

Molecular Endocrinology

Volumn 11, Issue 6, 1997, Pages 747-754

  Norris, John D ^a   Fan, Daju ^a   Kerner, Sandra A ^a   McDonnell, Donald P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; DNA BINDING; MUTATION; PRIORITY JOURNAL; REPORTER GENE; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0030910962     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.6.0008     Document Type: Article

References (38)

1. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
2. Smith DF, Toft DO 1993 Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
3. Beekman JM, Alan GF, Tsai SY, Tsai M, O'Malley BW 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1274
4. McDonnell DP, Nawaz Z, O'Malley BW 1991 In Situ distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol 11:4350-4355
5. Kumar V, Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
6. Blobel GA, Sieff CA, Orkin SH 1995 Ligand-dependent repression of the erythoid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15:3147-3153
7. Elgort MG, Zou A, Marschke KB, Allegretto EA 1996 Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-α1 promoter via a novel sequence. Mol Endocrinol 10:477-487
8. Stein B, Yang MX 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kB and C/EBPβ. Mol Cell Biol 15:4971-4979
9. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
10. Gaub M, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P 1990 Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63:1267-1276
11. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
12. Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
13. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
14. McDonnell DP, Clemm DL, Herman T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
15. Norris JD, Fan D, Wagner BL, McDonnell DP 1996 Identification of the sequences within the human C3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10:1605-1616
16. Dauvois S, Danielian PS, White R, Parker MG 1992 Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89:4037-4041
17. Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG 1990 Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87:6883-6887
18. Willson TM, Henke BR, Momtahen TM, Charifson PS, Batchelor KW, Lubahn DB, Moore LB, Oliver BB, Sauls HR, Triantafillou JA, Wolfe SG, Baer PG 1994 2-[4-(1, 2-Diphenylbut-1-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for bone over uterus in rats. J Med Chem 37:1550-1552
19. McDonnell DP, Vegeto E, O'Malley BW 1992 Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci USA 89:10563-10567
20. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP 1995 Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270: 22777-22782
21. Dana SL, Hoener PA, Wheeler DA, Lawrence CB, McDonnell DP 1994 Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol Endocrinol 8:1193-1207
22. Pierrat B, Heery DM, Chambon P, Losson R 1994 A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast. Gene 143:193-200
23. Fawell SE, Lees JA, White R, Parker MG 1990 Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962
24. Metzger D, Ali S, Bornert J-M, Chambon P 1995 Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542
25. Metzger D, White JH, Chambon P 1988 The human oestrogen receptor functions in yeast. Nature 334:31-36
26. Webster NJG, Green S, Tasset D, Ponglikitmongkol M, Chambon P 1989 The transactivation function located in the hormone-binding domain of the human oestrogen receptor is not encoded by a single exon. EMBO J 8:1441-1446
27. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P 1989 The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487
28. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L 1994 Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117
29. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-403
30. Hollenberg S, Evans R 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
31. Catherino WH, Wolf DM, Jordan VC 1995 A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. Mol Endocrinol 9:1053-1063
32. Le Douarin B, Zechel C, Gamier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
33. Onate SA, Tsai SY, Tsai M, O'Malley BW 1995 Sequence and characterizations of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
34. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952
35. Baur EV, Zechel C, Heery D, Heine MJS, Gamier JM, Vivat V, Douarin BL, Gronemeyer H, Chambon P, Losson R 1996 Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124
36. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
37. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW 1996 Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597
38. McDonnell DP, Nawaz Z, Densmore C, Clark J, Weigel NL, O'Malley BW 1991 High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J Steroid Biochem Mol Biol 39:291-297